- Home
- LEE vs CALC Comparison
LEE vs CALC Comparison
Compare LEE & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEE
- CALC
- Stock Information
- Founded
- LEE 1890
- CALC 2011
- Country
- LEE United States
- CALC United States
- Employees
- LEE N/A
- CALC N/A
- Industry
- LEE Newspapers/Magazines
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- LEE Consumer Discretionary
- CALC Health Care
- Exchange
- LEE Nasdaq
- CALC Nasdaq
- Market Cap
- LEE 53.9M
- CALC 44.7M
- IPO Year
- LEE N/A
- CALC N/A
- Fundamental
- Price
- LEE $9.54
- CALC $3.97
- Analyst Decision
- LEE
- CALC Strong Buy
- Analyst Count
- LEE 0
- CALC 4
- Target Price
- LEE N/A
- CALC $20.50
- AVG Volume (30 Days)
- LEE 13.9K
- CALC 38.9K
- Earning Date
- LEE 08-01-2024
- CALC 11-07-2024
- Dividend Yield
- LEE N/A
- CALC N/A
- EPS Growth
- LEE N/A
- CALC N/A
- EPS
- LEE N/A
- CALC N/A
- Revenue
- LEE $616,815,000.00
- CALC N/A
- Revenue This Year
- LEE N/A
- CALC N/A
- Revenue Next Year
- LEE N/A
- CALC N/A
- P/E Ratio
- LEE N/A
- CALC N/A
- Revenue Growth
- LEE N/A
- CALC N/A
- 52 Week Low
- LEE $7.56
- CALC $1.75
- 52 Week High
- LEE $15.89
- CALC $8.38
- Technical
- Relative Strength Index (RSI)
- LEE 58.76
- CALC 42.78
- Support Level
- LEE $8.54
- CALC $3.96
- Resistance Level
- LEE $9.41
- CALC $4.39
- Average True Range (ATR)
- LEE 0.34
- CALC 0.38
- MACD
- LEE 0.10
- CALC -0.05
- Stochastic Oscillator
- LEE 83.61
- CALC 2.83
About LEE Lee Enterprises Incorporated
Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high quality, trusted, intensely local news, information, advertising and marketing services. Its product portfolio includes digital subscription platforms, daily, weekly and monthly newspapers and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and its content and advertising is available in real time through the websites and mobile apps.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.